Research ArticleOriginal Article

LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients

Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136

References

  1. 1.↵
    2. Mercer TR,
    3. Dinger ME,
    4. Mattick JS.
    Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10: 155–9.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    2. Ponting CP,
    3. Oliver PL,
    4. Reik W.
    Evolution and functions of long noncoding RNAs. Cell. 2009; 136: 629–41.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    2. Gibb EA,
    3. Brown CJ,
    4. Lam WL.
    The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011; 10: 38.
    OpenUrlCrossRefPubMed
  4. 4.↵
    2. Li J,
    3. Tian H,
    4. Yang J,
    5. Gong Z.
    Long noncoding RNAs regulate cell growth, proliferation, and apoptosis. DNA Cell Biol. 2016; 35: 459–70.
    OpenUrlCrossRefPubMed
  5. 5.
    2. Peng WX,
    3. Koirala P,
    4. Mo YY.
    LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017; 36: 5661–7.
    OpenUrlCrossRefPubMed
  6. 6.↵
    2. Sun Q,
    3. Hao Q,
    4. Prasanth KV.
    Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018; 34: 142–57.
    OpenUrlCrossRefPubMed
  7. 7.↵
    2. Liao XH,
    3. Wang JG,
    4. Li LY,
    5. Zhou DM,
    6. Ren KH,
    7. Jin YT, et al.
    Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing α-tubulin acetylation in breast cancer. Cell Death Dis. 2016; 7: e2236.
  8. 8.↵
    2. Yuan JH,
    3. Yang F,
    4. Wang F,
    5. Ma JZ,
    6. Guo YJ,
    7. Tao QF, et al.
    A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25: 666–81.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    2. Wang R,
    3. Shi Y,
    4. Chen L,
    5. Jiang Y,
    6. Mao C,
    7. Yan B, et al.
    The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by lncRNA HOTAIR and chromatin remodeling factor LSH. Sci Rep. 2015; 5: 17826.
    OpenUrl
  10. 10.↵
    2. Gutschner T,
    3. Hammerle M,
    4. Eissmann M,
    5. Hsu J,
    6. Kim Y,
    7. Hung G, et al.
    The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013; 73: 1180–9.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    2. Su W,
    3. Feng S,
    4. Chen X,
    5. Yang X,
    6. Mao R,
    7. Guo C, et al.
    Silencing of long non-coding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res. 2018; 78: 3207–19.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    2. Moran VA,
    3. Perera RJ,
    4. Khalil AM.
    Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012; 40: 6391–400.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    2. Li W,
    3. Sun M,
    4. Zang C,
    5. Ma P,
    6. He J,
    7. Zhang M, et al.
    Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis. 2016; 7: e2225.
  14. 14.↵
    2. Jiang N,
    3. Meng X,
    4. Mi H,
    5. Chi Y,
    6. Li S,
    7. Jin Z, et al.
    Circulating lncRNA xloc_009167 serves as a diagnostic biomarker to predict lung cancer. Clin Chim Acta. 2018; 486: 26–33.
    OpenUrl
  15. 15.↵
    2. Yang L,
    3. Yang J,
    4. Li J,
    5. Shen X,
    6. Le Y,
    7. Zhou C, et al.
    MicroRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer. Sci Rep. 2015; 5: 13677.
    OpenUrl
  16. 16.↵
    2. Li J,
    3. Tian H,
    4. Pan J,
    5. Jiang N,
    6. Yang J,
    7. Zhou C, et al.
    Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer. Cancer Lett. 2017; 406: 36–46.
    OpenUrl
  17. 17.↵
    2. Guttman M,
    3. Amit I,
    4. Garber M,
    5. French C,
    6. Lin MF,
    7. Feldser D, et al.
    Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458: 223–7.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    2. Li K,
    3. Sun D,
    4. Gou Q,
    5. Ke X,
    6. Gong Y,
    7. Zuo Y, et al.
    Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells. Cancer Lett. 2018; 420: 80–90.
    OpenUrlCrossRefPubMed
  19. 19.↵
    2. Sun Y,
    3. Hu B,
    4. Wang Q,
    5. Ye M,
    6. Qiu Q,
    7. Zhou Y, et al.
    Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a. Cell Death Dis. 2018; 9: 85.
    OpenUrlCrossRefPubMed
  20. 20.↵
    2. Chen N,
    3. Guo D,
    4. Xu Q,
    5. Yang M,
    6. Wang D,
    7. Peng M, et al.
    Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma. Oncotarget. 2016; 7: 11271–83.
    OpenUrlPubMed
  21. 21.
    2. Huang B,
    3. Song JH,
    4. Cheng Y,
    5. Abraham JM,
    6. Ibrahim S,
    7. Sun Z, et al.
    Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene. 2016; 35: 4927–36.
    OpenUrl
  22. 22.
    2. Sun J,
    3. Wang X,
    4. Fu C,
    5. Wang X,
    6. Zou J,
    7. Hua H, et al.
    Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3. Mol Biol Rep. 2016; 43: 427–36.
    OpenUrlCrossRef
  23. 23.↵
    2. Liu C,
    3. Lin J.
    Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. Am J Transl Res. 2016; 8: 4095–105.
    OpenUrl
  24. 24.↵
    2. Vadaie N,
    3. Morris KV.
    Long antisense non-coding RNAs and the epigenetic regulation of gene expression. Biomol Concepts. 2013; 4: 411–5.
    OpenUrl
  25. 25.
    2. Villegas VE,
    3. Zaphiropoulos PG.
    Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci. 2015; 16: 3251–66.
    OpenUrlCrossRefPubMed
  26. 26.
    2. Carrieri C,
    3. Cimatti L,
    4. Biagioli M,
    5. Beugnet A,
    6. Zucchelli S,
    7. Fedele S, et al.
    Long non-coding antisense RNA controls UCHL1 translation through an embedded SINEB2 repeat. Nature. 2012; 491: 454–7.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    2. Yuan SX,
    3. Tao QF,
    4. Wang J,
    5. Yang F,
    6. Liu L,
    7. Wang LL, et al.
    Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma. Cancer Lett. 2014; 349: 87–94.
    OpenUrlCrossRefPubMed
  28. 28.↵
    2. Gao S,
    3. Lin Z,
    4. Li C,
    5. Wang Y,
    6. Yang L,
    7. Zou B, et al.
    TFPI2AS1, a novel lncRNA that inhibits cell proliferation and migration in lung cancer. Cell Cycle 2017; 16: 2249–58.
    OpenUrl
  29. 29.↵
    2. Zhang CL,
    3. Zhu KP,
    4. Ma XL.
    Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 2017; 396: 66–75.
    OpenUrl
  30. 30.↵
    2. Lepoivre C,
    3. Belhocine M,
    4. Bergon A,
    5. Griffon A,
    6. Yammine M,
    7. Vanhille L, et al.
    Divergent transcription is associated with promoters of transcriptional regulators. BMC Genomics. 2013; 14: 914.
    OpenUrlCrossRefPubMed
  31. 31.↵
    2. Kurihara M,
    3. Shiraishi A,
    4. Satake H,
    5. Kimura AP.
    A conserved noncoding sequence can function as a spermatocyte-specific enhancer and a bidirectional promoter for a ubiquitously expressed gene and a testis-specific long noncoding RNA. J Mol Biol. 2014; 426: 3069–93.
    OpenUrlCrossRefPubMed
  32. 32.↵
    2. Dimitrova N,
    3. Zamudio JR,
    4. Jong RM,
    5. Soukup D,
    6. Resnick R,
    7. Sarma K, et al.
    LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/s checkpoint. Mol Cell. 2014; 54: 777–90.
    OpenUrlCrossRefPubMed
  33. 33.↵
    2. Wei W,
    3. Pelechano V,
    4. Jarvelin AI,
    5. Steinmetz LM.
    Functional consequences of bidirectional promoters. Trends Genet. 2011; 27: 267–76.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    2. Nebbioso A,
    3. Tambaro FP,
    4. Dell’Aversana C,
    5. Altucci L.
    Cancer epigenetics: moving forward. PLoS Genet. 2018; 14: e1007362.
  35. 35.↵
    2. Rhee I,
    3. Bachman KE,
    4. Park BH,
    5. Jair KW,
    6. Yen RW,
    7. Schuebel KE, et al.
    DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002; 416: 552–6.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    2. Subhash S,
    3. Andersson PO,
    4. Kosalai ST,
    5. Kanduri C,
    6. Kanduri M.
    Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. Clin Epigenetics. 2016; 8: 106.
    OpenUrl
  37. 37.↵
    2. Yao X,
    3. Xing M,
    4. Ooi WF,
    5. Tan P,
    6. Teh BT.
    Epigenomic consequences of coding and noncoding driver mutations. Trends Cancer. 2016; 2: 585–605.
    OpenUrl
  38. 38.↵
    2. Wu W,
    3. Bhagat TD,
    4. Yang X,
    5. Song JH,
    6. Cheng Y,
    7. Agarwal R, et al.
    Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2013; 144: 956–66.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    2. Heilmann K,
    3. Toth R,
    4. Bossmann C,
    5. Klimo K,
    6. Plass C,
    7. Gerhauser C.
    Genome-wide screen for differentially methylated long noncoding RNAs identifies ESRP2 and lncRNA ESRP2-AS regulated by enhancer DNA methylation with prognostic relevance for human breast cancer. Oncogene. 2017; 36: 6446–61.
    OpenUrl
  40. 40.↵
    2. Huarte M.
    The emerging role of lncRNAs in cancer. Nat Med. 2015; 21: 1253–61.
    OpenUrlCrossRefPubMed
  41. 41.↵
    2. Panda S,
    3. Setia M,
    4. Kaur N,
    5. Shepal V,
    6. Arora V,
    7. Singh DK, et al.
    Noncoding RNA GINIR functions as an oncogene by associating with centrosomal proteins. PLoS Biol. 2018; 16: e2004204.
  42. 42.
    2. Schmitt AM,
    3. Chang HY.
    Long noncoding RNAs in cancer pathways. Cancer Cell. 2016; 29: 452–63.
    OpenUrlCrossRefPubMed
  43. 43.↵
    2. Xu TP,
    3. Wang WY,
    4. Ma P,
    5. Shuai Y,
    6. Zhao K,
    7. Wang YF, et al.
    Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EPHB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Oncogene. 2018; 37: 5020–36.
    OpenUrlPubMed
  44. 44.↵
    2. Qi P,
    3. Zhou XY,
    4. Du X.
    Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016; 15: 39.
    OpenUrlCrossRefPubMed
  45. 45.↵
    2. Yang Z,
    3. Li X,
    4. Yang Y,
    5. He Z,
    6. Qu X,
    7. Zhang Y.
    Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis. 2016; 7: e2389.
  46. 46.↵
    2. Park HS,
    3. Yeo HY,
    4. Chang HJ,
    5. Kim KH,
    6. Park JW,
    7. Kim BC, et al.
    Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer. Yonsei Med J. 2013; 54: 1362–9.
    OpenUrl
  47. 47.↵
    2. Hu B,
    3. Shi C,
    4. Jiang HX,
    5. Qin SY.
    Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis. Medicine (Baltimore). 2017; 96: e8261.
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords